These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 25586464
21. Self-monitoring of blood glucose in people with type 1 and type 2 diabetes living in France: the Entred study 2001. Lecomte P, Romon I, Fosse S, Simon D, Fagot-Campagna A. Diabetes Metab; 2008 Jun; 34(3):219-26. PubMed ID: 18343703 [Abstract] [Full Text] [Related]
22. Healthcare resource utilization and related financial costs associated with glucose lowering with either exenatide or basal insulin: A retrospective cohort study. Holden SE, Morgan CL, Qiao Q, Jenkins-Jones S, Berni ER, Currie CJ. Diabetes Obes Metab; 2017 Aug; 19(8):1097-1105. PubMed ID: 28218819 [Abstract] [Full Text] [Related]
23. Exenatide once weekly: opportunities in the primary care setting. Davidson JA, Nikkel C, Grimm M. Postgrad Med; 2013 May; 125(3):68-78. PubMed ID: 23748508 [Abstract] [Full Text] [Related]
25. Frequency of self-monitoring of blood glucose in patients with type 2 diabetes: association with hypoglycaemic events. Farmer A, Balman E, Gadsby R, Moffatt J, Cradock S, McEwen L, Jameson K. Curr Med Res Opin; 2008 Nov; 24(11):3097-104. PubMed ID: 18828957 [Abstract] [Full Text] [Related]
27. Evaluating once- and twice-daily self-monitored blood glucose testing strategies for stable insulin-treated patients with type 2 diabetes : the diabetes outcomes in veterans study. Hoffman RM, Shah JH, Wendel CS, Duckworth WC, Adam KD, Bokhari SU, Dalton C, Murata GH, Diabetes Outcome in Veterans Study. Diabetes Care; 2002 Oct; 25(10):1744-8. PubMed ID: 12351471 [Abstract] [Full Text] [Related]
28. Effect of the Glucagon-like Peptide-1 Analogue Exenatide Extended Release in Cats with Newly Diagnosed Diabetes Mellitus. Riederer A, Zini E, Salesov E, Fracassi F, Padrutt I, Macha K, Stöckle TM, Lutz TA, Reusch CE. J Vet Intern Med; 2016 Oct; 30(1):92-100. PubMed ID: 26700409 [Abstract] [Full Text] [Related]
32. Self-monitoring of blood glucose: a prerequisite for diabetes management in outcome trials. Schnell O, Hanefeld M, Monnier L. J Diabetes Sci Technol; 2014 May; 8(3):609-14. PubMed ID: 24876626 [Abstract] [Full Text] [Related]
33. Simplification of Insulin Regimen in Older Adults and Risk of Hypoglycemia. Munshi MN, Slyne C, Segal AR, Saul N, Lyons C, Weinger K. JAMA Intern Med; 2016 Jul 01; 176(7):1023-5. PubMed ID: 27273335 [No Abstract] [Full Text] [Related]
36. Effectiveness and tolerability of therapy with exenatide once weekly vs basal insulin among injectable-drug-naïve elderly or renal impaired patients with type 2 diabetes in the United States. Loughlin AM, Qiao Q, Nunes AP, Öhman P, Ezzy S, Yochum L, Clifford CR, Gately R, Dore DD, Seeger JD. Diabetes Obes Metab; 2018 Apr 01; 20(4):898-909. PubMed ID: 29193561 [Abstract] [Full Text] [Related]
37. NEW FOR YOU! These innovative products aim to help make diabetes self-management easier. Wynn P. Diabetes Self Manag; 2017 Mar 01; 34(2):24-7, 31. PubMed ID: 29757530 [No Abstract] [Full Text] [Related]
39. Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL). Davis TME, Giczewska A, Lokhnygina Y, Mentz RJ, Sattar N, Holman RR, EXSCEL Study Group. Cardiovasc Diabetol; 2022 Jun 27; 21(1):116. PubMed ID: 35761271 [Abstract] [Full Text] [Related]
40. Efficacy and safety of exenatide once-weekly vs exenatide twice-daily in Asian patients with type 2 diabetes mellitus. Ji L, Onishi Y, Ahn CW, Agarwal P, Chou CW, Haber H, Guerrettaz K, Boardman MK. J Diabetes Investig; 2013 Jan 29; 4(1):53-61. PubMed ID: 24843631 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]